MedPath

Test-retest reproducibility of whole body [18F]FDG PET-CT in patients with malignant lung lesions.

Completed
Conditions
advanced stage cancer
metastatic cancer
10027476
Registration Number
NL-OMON39195
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
12
Inclusion Criteria

Malignant lung lesions (of any primary)
18 years and older
Expected life expectancy of < 8 year
Tumor larger than 3 cm diameter
written informed consent

Exclusion Criteria

Pregnant or lactating
Known diabetes mellitus type I and II
Chemotherapy during past 4 weeks

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Reproducibility of various SUV measures, metabolic and anatomic volume<br /><br>measurements on whole body [18F]FDG PET-CT.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Not applicable.</p><br>
© Copyright 2025. All Rights Reserved by MedPath